Dr. Wyatt is actively involved in clinical care and clinical research in HIV-related kidney disease. Her research has focused on defining the epidemiology of kidney disease among HIV-infected individuals, including those with comorbid risk factors such as Hepatitis C co-infection and diabetes. She has established collaborations with several large HIV cohorts, and is the director of the clinical core of a longstanding P01 investigating the pathogenesis of HIV-associated nephropathy. She is also the PI of an R01 evaluating the renal safety of oral pre-exposure prophylaxis to prevent HIV infection.
At the completion of this educational session, learners will:
- Identify HIV-infected individuals who are at higher risk for acute and chronic kidney disease or ART nephrotoxicity.
- Understand the risk of nephrotoxicity and approaches to diagnosis and management in adults initiating therapy with TDF-containing ART or PrEP.
- Describe recent advances in nephrology and ART that may impact the management of HIV-infected individuals with kidney disease.
This CME activity was approved for AMA PRA Category 1 Credit™
on October 14, 2014 and will terminate October, 2017.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Wyatt (Presenter) had no relevant financial relationships to disclose. Dr. Wyatt supported her presentation and clinical recommendations with the best available evidence from the medical literature, and submitted her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.